Markus Blaess

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Respiratory Syndrome Coronavirus

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Markus Blaess, Rene Csuk, Teresa Schätzl, Hans-Peter Deigner
Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs. International journal of molecular sciences 25 (17) (2024)
Markus Blaess, Lars Kaiser, Oliver Sommerfeld, Rene Csuk, Hans-Peter Deigner
Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19. International journal of molecular sciences 22 (4) (2021)
Lars Kaiser, Helga Weinschrott, Isabel Quint, Markus Blaess, Rene Csuk, Manfred Jung, Matthias Kohl, Hans-Peter Deigner
Metabolite Patterns in Human Myeloid Hematopoiesis Result from Lineage-Dependent Active Metabolic Pathways. International journal of molecular sciences 21 (17) (2020)
Markus Blaess, Lars Kaiser, Martin Sauer, Rene Csuk, Hans-Peter Deigner
COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. International journal of molecular sciences 21 (14) (2020)
Markus Blaess, Hans-Peter Deigner
Derailed Ceramide Metabolism in Atopic Dermatitis (AD): A Causal Starting Point for a Personalized (Basic) Therapy. International journal of molecular sciences 20 (16) (2019)